FDA CDRH Variance Approval Letter to Smack Shack

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Smack Shack, dated March 19, 2025. This letter signifies an approval for a specific variance requested by the company. However, the content of the variance itself and the specific product or process it pertains to are not detailed in the provided metadata, and the document content is unavailable.

As this is a specific approval for a named entity, it is unlikely to impose new general obligations on other regulated entities. Compliance officers should note that this is an individual approval and not a general policy change. Further details would require accessing the attached PDF, which is currently unavailable.